Peter Tippett

Last updated
Peter Tippett
Peter S. Tippett, MD, PhD.jpg
Born
Peter S. Tippett

1953 (age 6970)
NationalityAmerican
Education Kalamazoo College, B.A., Biology (1975); Rockefeller University, Research Assistant to Nobel Prize winner Robert Bruce Merrifield (1975-1976); Case Western Reserve University, Ph.D. in Biochemistry (1981); Case Western Reserve University, Doctor of Medicine (1983); American Board of Internal Medicine, Diplomate Certified, Internal Medicine (1987)
Medical career
Profession Medicine
Field Internal Medicine
Institutions Case Western Reserve University Department of Biochemistry; The Pacific Foundation for the Advancement of Science and Medicine; Cleveland Metropolitan General Hospital; Euclid Hospital; Daniel Freeman Marina Hospital
Sub-specialties Biochemistry
ResearchSolid Phase Peptide Synthesis of Immunoglobulin Hypervariable Regions; Synthesis of Smallest Active Complement Peptides from C3 and C5; Hepatic Glucokinase -- Kinetics, Regulation, and Turnover; Palmitoyl CoA's Role as a Metabolic Effector; Protein-lipid Interactions; Measurement of Critical Micelle Concentrations; Hypomagnesemia, Meperidine Related Seizures in Renal Failure; Cardiologic Effect of Heat Stroke.

Peter S. Tippett (born 1953) is an American physician, researcher, and inventor known for contributions to information security, clinical medicine, and technology. These contributions include the development of the anti-virus program "Corporate Vaccine". [1] Tippett was Vice President of Verizon's Innovations Incubator and Chief Medical Officer for Verizon Enterprise Services from 2009 to 2015. He is currently the Founder and CEO of careMESH Inc. [2]

Contents

Early life and education

Born in 1953 and raised in Dearborn, Michigan, Tippett is an alumnus of Kalamazoo College and holds both a Ph.D. and M.D. from Case Western Reserve University School of Medicine. He studied at the Rockefeller University in New York under Nobel Prize winner Robert Bruce Merrifield, directing his doctoral research efforts toward the metabolic indicators of peptide synthesis. He completed his internship and residency in Internal Medicine at Cleveland Metropolitan General Hospital, and spent 1975-1985 engaged in biochemical research.

Work history

While engaged in research at Case Western Reserve, Tippett moonlighted as an emergency room physician and instructor in Emergency and Outpatient Medicine and spent much of his early clinical career (1989-1995) in Emergency Medicine in Ohio and California. He received his board certification in Internal Medicine in 1987. Between 1993 and 2000, he served on the board of the Computer Ethics Institute. [3]

He served as executive director of The Pacific Foundation for Science and Medicine from 1988 to 1992, an intersection of his clinical career with an emerging focus on technology, particularly in the arena of cybersecurity as well as the use and access protocols of the Internet. It was in his role as president and chairman of Certus International, a publisher and developer of PC anti-virus and security software, that Tippett applied his research insights as a biochemist to the concept of computer "viruses" to develop the anti-virus software, "Vaccine," which was later purchased by Symantec in 1992. [4] His CEO role with Cybertrust led to a merger of Cybertrust by Verizon and to Tippett's role in the Verizon healthcare and security innovations divisions. Tippett served as chairman of the Alliance for Internet Security in 2000. [5] He represented Verizon on the board of directors of The Open Identity Exchange (OIX) [6] and the Information Card Foundation. [7]

Technological achievements

In addition to being credited with the development of one of the first anti-virus programs, "Vaccine", Tippett pioneered and commercialized a string of now-common technologies including what is now called the "Recovery Disk," processor image signatures, using hash-tables for trusted file execution and anomaly detection, aspects of mail merge and "un-do." [1] He ran a bulletin board system for CP/M software before the first IBM PC was created and was president of the Cleveland Osborne Group (a user group for the computers of the Osborne Computer Corporation) in the early 1980s.

As chief scientist for ICSA.net, Tippett was one of a handful of experts to identify and address [8] the ILOVEYOU virus that broke in May 2000 [9] and provided key information to the Department of Justice about David Smith, the writer of the Melissa virus. [10] He was featured and on the cover of the August 2000 issue of Time Digital magazine. [11]

Professional activities

Tippett's work in the cybersecurity space has led to roles as speaker, contributor and advisor to government and private sector organizations. From 2003-2005, [12] he served on the President's Information Technology Committee (PITAC), established by Congress in 1997 under the High Performance Computing Act of 1991 to "guide the Administration's efforts to accelerate the development and adoption of information technologies vital for American prosperity in the 21st century." [13]

The U.S. Chamber of Commerce awarded Tippett its first Leadership in Health Care Award at the Chamber’s first annual Health Care Summit (2012) for his leadership of Verizon's incubator. [14] Tippett was also Chief Scientist for ICSA Labs and previously served as president of the International Computer Security Association. [15]

Tippett is currently an Adjunct Professor, Division of General Medical Sciences at Case Western Reserve University School of Medicine. [16]

In November 2017, T.E.N., a technology and information security executive networking and relationship-marketing firm, announced that Tippett was the recipient of the 2017 ISE® Luminary Leadership Award. [17]

Clinical publications

Related Research Articles

<span class="mw-page-title-main">Bioterrorism</span> Terrorism involving biological agents

Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents include bacteria, viruses, insects, fungi, and/or toxins, and may be in a naturally occurring or a human-modified form, in much the same way as in biological warfare. Further, modern agribusiness is vulnerable to anti-agricultural attacks by terrorists, and such attacks can seriously damage economy as well as consumer confidence. The latter destructive activity is called agrobioterrorism and is a subtype of agro-terrorism.

<span class="mw-page-title-main">Vaccine</span> Pathogen-derived preparation that provides acquired immunity to an infectious disease

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious or malignant disease. The safety and effectiveness of vaccines has been widely studied and verified. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and to further recognize and destroy any of the microorganisms associated with that agent that it may encounter in the future.

A cancer vaccine is a vaccine that either treats existing cancer or prevents development of cancer. Vaccines that treat existing cancer are known as therapeutic cancer vaccines or tumor antigen vaccines. Some of the vaccines are "autologous", being prepared from samples taken from the patient, and are specific to that patient.

<span class="mw-page-title-main">ESET NOD32</span> Computer protection software

ESET NOD32 Antivirus, commonly known as NOD32, is an antivirus software package made by the Slovak company ESET. ESET NOD32 Antivirus is sold in two editions, Home Edition and Business Edition. The Business Edition packages add ESET Remote Administrator allowing for server deployment and management, mirroring of threat signature database updates and the ability to install on Microsoft Windows Server operating systems.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, also known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. The United States Centers for Disease Control and Prevention (CDC) estimates that vaccination against influenza reduces sickness, medical visits, hospitalizations, and deaths. Immunized workers who do catch the flu return to work half a day sooner on average. Vaccine effectiveness in those over 65 years old remains uncertain due to a lack of high-quality research.

<span class="mw-page-title-main">Live attenuated influenza vaccine</span> Flu vaccine that is sprayed into the nose

Live attenuated influenza vaccine (LAIV) is a type of influenza vaccine in the form of a nasal spray that is recommended for the prevention of influenza.

In academia, computational immunology is a field of science that encompasses high-throughput genomic and bioinformatics approaches to immunology. The field's main aim is to convert immunological data into computational problems, solve these problems using mathematical and computational approaches and then convert these results into immunologically meaningful interpretations.

A mimotope is often a peptide, and mimics the structure of an epitope. Because of this property it causes an antibody response similar to the one elicited by the epitope. An antibody for a given epitope antigen will recognize a mimotope which mimics that epitope. Mimotopes are commonly obtained from phage display libraries through biopanning. Vaccines utilizing mimotopes are being developed. Mimotopes are a kind of peptide aptamers.

<span class="mw-page-title-main">Rabies vaccine</span> Vaccines to prevent rabies in humans and animals

The rabies vaccine is a vaccine used to prevent rabies. There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies before, and, for a period of time, after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

<span class="mw-page-title-main">Pandemrix</span> Flu vaccine

Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) and patented in September 2006.

<span class="mw-page-title-main">Gajendra Pal Singh Raghava</span>

Gajendra Pal Singh Raghava is an Indian bio-informatician and head of computational biology at the Indraprastha Institute of Information Technology.

A subunit vaccine is a vaccine that contains purified parts of the pathogen that are antigenic, or necessary to elicit a protective immune response. Subunit vaccine can be made from dissembled viral particles in cell culture or recombinant DNA expression, in which case it is a recombinant subunit vaccine.

<span class="mw-page-title-main">Networking and Information Technology Research and Development</span> NiTRD

The Networking and Information Technology Research and Development (NITRD) program consists of a group of U.S. federal agencies to research and develop information technology (IT) capabilities to empower Federal missions; support U.S. science, engineering, and technology leadership; and bolster U.S. economic competitiveness.

<span class="mw-page-title-main">H5N1 vaccine</span> Vaccine designed to provide immunity against H5N1 influenza

A H5N1 vaccine is an influenza vaccine intended to provide immunization to influenza A virus subtype H5N1.

<span class="mw-page-title-main">Ebola vaccine</span> Vaccine against Ebola

Ebola vaccines are vaccines either approved or in development to prevent Ebola. As of 2022, there are only vaccines against the Zaire ebolavirus. The first vaccine to be approved in the United States was rVSV-ZEBOV in December 2019. It had been used extensively in the Kivu Ebola epidemic under a compassionate use protocol. During the early 21st century, several vaccine candidates displayed efficacy to protect nonhuman primates against lethal infection.

The Coalition for Epidemic Preparedness Innovations (CEPI) is a foundation that takes donations from public, private, philanthropic, and civil society organisations, to finance independent research projects to develop vaccines against emerging infectious diseases (EID).

<span class="mw-page-title-main">History of COVID-19 vaccine development</span> Scientific work to develop a vaccine for COVID-19

SARS-CoV-2, the virus that causes COVID-19, was isolated in late 2019. Its genetic sequence was published on 11 January 2020, triggering the urgent international response to prepare for an outbreak and hasten development of a preventive COVID-19 vaccine. Since 2020, vaccine development has been expedited via unprecedented collaboration in the multinational pharmaceutical industry and between governments. By June 2020, tens of billions of dollars were invested by corporations, governments, international health organizations, and university research groups to develop dozens of vaccine candidates and prepare for global vaccination programs to immunize against COVID‑19 infection. According to the Coalition for Epidemic Preparedness Innovations (CEPI), the geographic distribution of COVID‑19 vaccine development shows North American entities to have about 40% of the activity, compared to 30% in Asia and Australia, 26% in Europe, and a few projects in South America and Africa.

<span class="mw-page-title-main">EpiVacCorona</span> EpiVacCorona vaccine against COVID-19

EpiVacCorona is a peptide-based vaccine against COVID-19 developed by the Russian VECTOR Center of Virology. The lack of protective effectiveness of EpiVacCorona, which is still in use in Russia, has been reported in scientific literature and in the media. The vaccine consists of three chemically synthesized peptides that are conjugated to a large carrier protein. This protein is a fusion product of a viral nucleocapsid protein and a bacterial MBP protein. A phase III clinical trial to show whether or not the vaccine can protect people against COVID-19 was launched in November 2020 with more than three thousand participants. The conclusions and results of the trial have not been made public.

Software for COVID-19 pandemic mitigation takes many forms. It includes mobile apps for contact tracing and notifications about infection risks, vaccine passports, software for enabling – or improving the effectiveness of – lockdowns and social distancing, Web software for the creation of related information services, and research and development software. A common issue is that few apps interoperate, reducing their effectiveness.

<span class="mw-page-title-main">Ramakanth Sarabu</span> Indian chemist (1955–2021)

Ramakanth Sarabu was an Indian organic chemist. He is known for his contributions in diabetes research, specifically the work of Glucokinase activation as a treatment therapy for type 2 diabetes.

References

  1. 1 2 "PC Mag". 1989-04-25.
  2. "careMESH". careMESH. Retrieved 2020-04-23.
  3. "Computer Ethics Institute". Archived from the original on 2013-12-13. Retrieved 2013-12-10.
  4. "Cybertrust". 2005-08-30. Archived from the original on 2005-08-30. Retrieved 2020-04-23.
  5. http://www.thefreelibrary.com/650-Member+Alliance+for+Internet+Security+Unveils+Tool+to+Detect...-a060577625 [ dead link ]
  6. "Board of Directors | Open Identity Exchange". Archived from the original on 2013-11-10. Retrieved 2013-12-10.
  7. "BOARD OF DIRECTORS". Archived from the original on 2016-01-22.
  8. Grossman, Lev (2000-05-15). "Attack of the Love Bug". Time. ISSN   0040-781X . Retrieved 2020-04-23.
  9. Max, Kevin. "I Love You, I Kill You: Amorous Virus Invades the Email World". TheStreet. Retrieved 2020-04-23.
  10. Smothers, Ronald (1999-12-10). "Man Pleads Guilty to Creating Melissa Virus". The New York Times. ISSN   0362-4331 . Retrieved 2020-04-23.
  11. Time (magazine) [ dead link ]
  12. "The Networking and Information Technology Research and Development (NITRD) Program". www.nitrd.gov. Retrieved 2020-04-23.
  13. "Historical Documents". www.nitrd.gov. Retrieved 2020-04-23.
  14. http://www.emrandehrnew.com/2012/11/04/verizons-dr-peter-tippett-receives-u-s-chambers-first-leadership-in-health-care-award/%5B%5D
  15. "Information Systems Security Association". ISSA International. Retrieved 2020-04-23.
  16. "School of Medicine Faculty < Case Western Reserve University". bulletin.case.edu. Retrieved 2020-04-23.
  17. "ISE Awards". ten-inc.com. Retrieved 2020-04-23.